Judge: Investors Repackaged Previously Denied Arguments Over Offering Documents
SAN FRANCISCO — A federal judge in California granted a biopharmaceutical company’s motion to dismiss investors’ amended class action against it for allegedly failing to disclose the findings from clinical trials...To view the full article, register now.
Already a subscriber? Click here to view full article